Overview

Minimally Invasive Surgery Market Overview:

Minimally invasive surgery enable surgeons to make fewer and smaller incisions thereby reducing the amount of blood loss. These procedures have been revolutionized by advancements in minimally invasive surgery devices. The use of minimally invasive technologies has improved patient outcomes and recovery around the world. By using voice control over a networked operating room, surgeons can advance video imaging through minimally invasive and robotic procedures. Minimally invasive robotic procedures provide surgeons with precision devices that use the same small incisions as conventional laparoscopy. The robotic system offers broader visualization of the operative field and precise control of minimally invasive surgery devices, which are two key differences.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Minimally Invasive Surgery Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Minimally Invasive Surgery Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Minimally Invasive Surgery Market:
• Abbott Laboratories
• B. Braun Melsungen
• AG, Becton, Dickinson and Company
• Boston Scientific Corporation
• CONMED Corporation
• Johnson & Johnson Services, Inc.
• Medtronic plc,
• Smith & Nephew plc
• Stryker Corporation
• Zimmer Biomet
• Medline Industries, Inc.
• Apollo Hospitals Enterprise Limited
• Huntington Hospital
• Johns Hopkins Hospital
• Massachusetts General Hospital
• Rutland Medical Center
• Saint Michael's Hospital
• Singapore General Hospital
• The Ottawa Hospital
• University of Pittsburgh Medical Center
• Washington Hospital Healthcare System
(Note: The list of the major players will be updated with the latest market scenario and trends)

Minimally Invasive Surgery Market Segmentation:
By Procedure
• Laparoscopic Surgery
• Robotic Surgery
• Endoscopic Mucosal Resection
• Endoscopic Submucosal Dissection
• Transcatheter
By Disease Indication
• Orthopedic Surgery
 o Knee
 o Spine
 o Shoulder
 o Others
• Cardiac Surgery
 o Mitral Valve
 o Aortic Valve
 o Structural Heart Disease
 o Tricuspid Valve
 o Others
• General Surgery
 o Gastrointestinal Surgery
 o Hepatobiliary & Pancreatic Surgery
• Urology Surgery
• Thoracic Surgery
• Gynecology Surgery
• Vascular Surgery
• Cancer Surgery
• Breast Surgery
• Ear, Nose, and Throat Surgery
• Bariatric Surgery
• Cosmetic/Plastic Surgery
• Neurosurgery
• Others
By End-user
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Minimally Invasive Surgery Market By Procedure, By Disease Indication, By End-user and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- Procedure launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1. Objectives of the Study
  1.2. Market Definition
  1.3. Market Scope
       1.3.1. Years Considered for the Study
       1.3.2. Market Covered
  1.4. Currency
  1.5. Limitations
  1.6. Stakeholders

2. Research Methodology
  2.1. Research Data
       2.1.1. Secondary Data
              2.1.1.1. Key Data from Secondary Sources
       2.1.2. Primary Data
              2.1.2.1. Key Data from Primary Sources
  2.2. Market Size Estimation
  2.3. Market Breakdown and Data Triangulation
  2.4. Assumptions for the Study  

3. Executive Summary
  3.1. Market Outlook
  3.2. Segment Outlook
  3.3. Competitive Insights

4. Minimally Invasive Surgery Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Technology Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of Minimally Invasive Surgery Market Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Minimally Invasive Surgery Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Technology Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Technology Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. Minimally Invasive Surgery Market, By Procedure Historical Analysis and Forecast 2022-2028 (USD Million)
  7.1. Laparoscopic Surgery
  7.2. Robotic Surgery
  7.3. Endoscopic Mucosal Resection
  7.4. Endoscopic Submucosal Dissection
  7.5. Transcatheter

8. Minimally Invasive Surgery Market, By Disease Indication Historical Analysis and Forecast 2022-2028 (USD Million)  
  8.1. Orthopedic Surgery
       8.1.1. Knee
       8.1.2. Spine
       8.1.3. Shoulder
       8.1.4. Others
  8.2. Cardiac Surgery
       8.2.1. Mitral Valve
       8.2.2. Aortic Valve
       8.2.3. Structural Heart Disease
       8.2.4. Tricuspid Valve
       8.2.5. Others
  8.3. General Surgery
       8.3.1. Gastrointestinal Surgery
       8.3.2. Hepatobiliary & Pancreatic Surgery
  8.4. Urology Surgery
  8.5. Thoracic Surgery
  8.6. Gynecology Surgery
  8.7. Vascular Surgery
  8.8. Cancer Surgery
  8.9. Breast Surgery
  8.10. Ear, Nose, and Throat Surgery
  8.11. Bariatric Surgery
  8.12. Cosmetic/Plastic Surgery
  8.13. Neurosurgery
  8.14. Others

9. Minimally Invasive Surgery Market, By End-user Historical Analysis and Forecast 2022-2028 (USD Million)  
  9.1. Hospitals
  9.2. Clinics
  9.3. Ambulatory Surgical Centers
  9.5. Others

10. North America Minimally Invasive Surgery Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   10.1. Introduction
   10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         10.2.1. U.S.A
         10.2.2. Canada
         10.2.3. Mexico
   10.3. Market Size (USD Million) Forecast for North America 2022-2028

11. Latin America Minimally Invasive Surgery Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   11.1. Introduction
   11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         11.2.1. Brazil
         11.2.2. Venezuela
         11.2.3. Argentina
         11.2.4. Rest of Latin America
   11.3. Market Size (USD Million) Forecast for Latin America 2022-2028

12. Europe Minimally Invasive Surgery Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   12.1. Introduction
   12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         12.2.1. Germany
         12.2.2. U.K        
         12.2.3. France
         12.2.4. Italy
         12.2.5. Spain
         12.2.6. Russia
         12.2.7. Poland
         12.2.8. Rest of Europe
   12.3. Market Size (USD Million) Forecast for Europe 2022-2028

13. Asia Pacific Minimally Invasive Surgery Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   13.1. Introduction
   13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         13.2.1. Japan
         13.2.2. China
         13.2.3. India
         13.2.4. Australia and New Zealand
         13.2.5. ASEAN
         13.2.6. Rest of Asia Pacific
   13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   14.1. Introduction
   14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         14.2.1. GCC
         14.2.2. Israel
         14.2.3. South Africa
         14.2.4. Rest of MEA
   14.3. Market Size (USD Million) Forecast for MEA 2022-2028

15. Market Share Analysis and Competitive Landscape  
   15.1. Global Landscape - Key Players, Revenue and Presence
   15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   15.3. Global Emerging Companies
   15.4. North America - Market Share Analysis and Key Regional Players
   15.5. Europe - Market Share Analysis and Key Regional Players
   15.6. Asia Pacific - Market Share Analysis and Key Regional Players
   15.7. Global Key Player - Growth Matrix

16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Procedures Offered and Financial Layouts)
   16.1. Abbott Laboratories
         16.1.1. Company Overview
         16.1.2. Procedure Portfolio
         16.1.3. SWOT Analysis
         16.1.4. Financial Overview
         16.1.5. Strategic Overview
   16.2. B. Braun Melsungen
         16.2.1. Company Overview
         16.2.2. Procedure Portfolio
         16.2.3. SWOT Analysis
         16.2.4. Financial Overview
         16.2.5. Strategic Overview
   16.3. AG, Becton, Dickinson and Company
         16.3.1. Company Overview
         16.3.2. Procedure Portfolio
         16.3.3. SWOT Analysis
         16.3.4. Financial Overview
         16.3.5. Strategic Overview
   16.4. Boston Scientific Corporation
         16.4.1. Company Overview
         16.4.2. Procedure Portfolio
         16.4.3. SWOT Analysis
         16.4.4. Financial Overview
         16.4.5. Strategic Overview
   16.5. CONMED Corporation
         16.5.1. Company Overview
         16.5.2. Procedure Portfolio
         16.5.3. SWOT Analysis
         16.5.4. Financial Overview
         16.5.5. Strategic Overview          
   16.6. Johnson & Johnson Services, Inc.
         16.6.1. Company Overview
         16.6.2. Procedure Portfolio
         16.6.3. SWOT Analysis
         16.6.4. Financial Overview
         16.6.5. Strategic Overview    
   16.7. Medtronic plc,
         16.7.1. Company Overview
         16.7.2. Procedure Portfolio
         16.7.3. SWOT Analysis
         16.7.4. Financial Overview
         16.7.5. Strategic Overview
   16.8. Smith & Nephew plc
         16.8.1. Company Overview
         16.8.2. Procedure Portfolio
         16.8.3. SWOT Analysis
         16.8.4. Financial Overview
         16.8.5. Strategic Overview
   16.9. Stryker Corporation
         16.9.1. Company Overview
         16.9.2. Procedure Portfolio
         16.9.3. SWOT Analysis
         16.9.4. Financial Overview
         16.9.5. Strategic Overview
   16.10. Zimmer Biomet
         16.10.1. Company Overview
         16.10.2. Procedure Portfolio
         16.10.3. SWOT Analysis
         16.10.4. Financial Overview
         16.10.5. Strategic Overview
   16.11. Medline Industries, Inc.
         16.11.1. Company Overview
         16.11.2. Procedure Portfolio
         16.11.3. SWOT Analysis
         16.11.4. Financial Overview
         16.11.5. Strategic Overview          
   16.12. Apollo Hospitals Enterprise Limited
         16.12.1. Company Overview
         16.12.2. Procedure Portfolio
         16.12.3. SWOT Analysis
         16.12.4. Financial Overview
         16.12.5. Strategic Overview      
   16.13. Huntington Hospital
         16.13.1. Company Overview
         16.13.2. Procedure Portfolio
         16.13.3. SWOT Analysis
         16.13.4. Financial Overview
         16.13.5. Strategic Overview
   16.14. Johns Hopkins Hospital
         16.14.1. Company Overview
         16.14.2. Procedure Portfolio
         16.14.3. SWOT Analysis
         16.14.4. Financial Overview
         16.14.5. Strategic Overview
   16.15. Massachusetts General Hospital
         16.15.1. Company Overview
         16.15.2. Procedure Portfolio
         16.15.3. SWOT Analysis
         16.15.4. Financial Overview
         16.15.5. Strategic Overview          
   16.16. Rutland Medical Center
         16.16.1. Company Overview
         16.16.2. Procedure Portfolio
         16.16.3. SWOT Analysis
         16.16.4. Financial Overview
         16.16.5. Strategic Overview  
   16.17. Saint Michael's Hospital
         16.17.1. Company Overview
         16.17.2. Procedure Portfolio
         16.17.3. SWOT Analysis
         16.17.4. Financial Overview
         16.17.5. Strategic Overview
   16.18. Singapore General Hospital
         16.18.1. Company Overview
         16.18.2. Procedure Portfolio
         16.18.3. SWOT Analysis
         16.18.4. Financial Overview
         16.18.5. Strategic Overview      
   16.19. The Ottawa Hospital
         16.19.1. Company Overview
         16.19.2. Procedure Portfolio
         16.19.3. SWOT Analysis
         16.19.4. Financial Overview
         16.19.5. Strategic Overview
   16.20. University of Pittsburgh Medical Center
         16.20.1. Company Overview
         16.20.2. Procedure Portfolio
         16.20.3. SWOT Analysis
         16.20.4. Financial Overview
         16.2-.5. Strategic Overview
   16.21. Washington Hospital Healthcare System
         16.21.1. Company Overview
         16.21.2. Procedure Portfolio
         16.21.3. SWOT Analysis
         16.21.4. Financial Overview
         16.21.5. Strategic Overview

17. Pre and Post COVID-19 Impact
   17.1. Positive influence on the healthcare industry
   17.2. The financial disruption of the manufacturing sector
   17.3. Impact of COVID-19 on emerging companies
   17.4. Significant mandates in the regulations initiated by healthcare administrations
   17.5. The overall economic slowdown of the developing and developed nations

18. FutureWise SME Key Takeaway Points for Client

Tables

Figures